Dihydromyricetin and Salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy

<h3>Background</h3><p dir="ltr">Progressive accumulation of α-synuclein is a key step in the pathological development of Parkinson’s disease. Impaired protein degradation and increased levels of α-synuclein may trigger a pathological aggregation <i>in vitro</i>...

Full description

Saved in:

Bibliographic Details
Main Author:	Jia-Zhen Wu (6844793) (author)
Other Authors:	Mustafa Ardah (2134240) (author), Caroline Haikal (5471201) (author), Alexander Svanbergsson (6844796) (author), Meike Diepenbroek (6844799) (author), Nishant N. Vaikath (2901785) (author), Wen Li (143214) (author), Zhan-You Wang (358606) (author), Tiago F. Outeiro (191379) (author), Omar M. El-Agnaf (3172641) (author), Jia-Yi Li (24812) (author)
Published:	2019
Subjects:	Biomedical and clinical sciences Neurosciences chaperone-mediated autophagy macroautophagy alpha-synuclein protein aggregation Parkinson disease lysosomal-associated membrane protein
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Dihydromyricetin and Salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy

Similar Items